Novartis' first-in-class drug data 'encouraging'
Swiss drugs firm Novartis are claiming success in its latest treatment for hypertension. Aliskiren - the first in a new class of antihypertensive drugs has shown to be effective as a single treatment for patients with high blood pressure.